Ischemic heart disease Board decisions

The veteran's service connection for coronary artery disease, myocardial infarction, and atrial fibrillation was granted an earlier effective date of September 16, 2021. The issue of an even earlier effective date for special monthly compensation (SMC) at the housebound rate was remanded.

The veteran's claims for higher ratings for service-connected conditions were partially granted. The veteran is entitled to a 60 percent rating for coronary artery disease, a 10 percent rating for diabetic peripheral neuropathy, and a noncompensable rating for erectile dysfunction, all effective May 11, 2021. However, the claim for a compensable rating for prostate cancer was denied.

The veteran's service connection for bladder cancer and hypertension due to herbicide exposure was granted. The claim for a heart condition other than hypertension was denied.

Service connection for bilateral hearing loss, tinnitus, right ankle disability, and coronary artery disease was denied. Service connection for left ankle, right wrist, and left wrist disabilities was remanded.

The Board remanded the veteran's claims for service connection of hepatic steatosis and heart disorder due to exposure at Camp Lejeune. The veteran will receive new examinations.

The veteran's service connection for bladder cancer and hypertension due to herbicide exposure was granted. The claim for a heart condition other than hypertension was denied.

The veteran's claim for service connection for rheumatic heart disease was granted. The claim for hypertensive vascular disease was remanded.

The Board denied an earlier effective date for the award of service connection for CAD and a higher initial disability rating for CAD. The Veteran's claim was not granted as there is no evidence of ischemic heart disease or CAD prior to March 2, 2012.

The veteran's service connection for diabetes, ischemic heart disease, chronic kidney disease, and peripheral neuropathies was granted effective August 10, 2022.

The appeal for service connection of heart disease, including ischemic heart disease and cardiomyopathy, has been dismissed because the veteran opted into the modernized review system.

The veteran's claim for a higher rating for coronary artery disease was denied. The claim for service connection for an acquired psychiatric disorder, including PTSD, was remanded for further evaluation.

The Board denied service connection for diabetes mellitus, type II, and a heart condition due to lack of evidence showing the Veteran's service in Vietnam or exposure to herbicide agents.

The Board remanded the issues related to compensation for residuals of prostate gland disorder, heart disorder, heart attack, and degenerative arthritis. The Veteran contends that these conditions were caused by a VA-provided biopsy in December 2014.

The veteran's claim for service connection for sleep apnea as secondary to diabetes was granted. The effective date for coronary artery disease was set to December 1, 2021. Other issues were remanded.

The Board denied service connection for ischemic heart disorder and Parkinson's disease but remanded the claim for prostate cancer.

The veteran's service connection claims for depressive disorder, anxiety, obstructive sleep apnea (OSA), hypertension (HTN), and coronary artery disease were granted.

The veteran withdrew all appeals related to increased evaluation of arteriosclerotic heart disease and service connection for various types of neuropathy. The Board dismissed the case as there are no remaining issues.

The veteran's claim for service connection for PTSD was granted based on new evidence, but denied for other conditions. The effective date for CAD service connection was granted as June 22, 2023.

The veteran's claim for a higher rating for tinnitus was denied. All other claims were remanded for further review.

The Board denied the veteran's request for an earlier effective date for a 100% rating for coronary artery disease and Dependents' Educational Assistance benefits.